Clinical Trial Update: Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes

View source ↗

Summary

This clinical trial update discusses safety data collection for pregnant subjects exposed to ibrefungerp and potential infant outcomes. The study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Vulvovaginal Candidiasis

Drugs mentioned

• Ibrexafungerp (ibrexafungerp)

Snippet

Sponsor: Scynexis, Inc. | Conditions: Vulvovaginal Candidiasis, Candida Infection | Status: RECRUITING